Biotech RadarJobs updated

COMPANY

TECLens

HQ: Stamford, CT source · teclens.com ↗

Location: Stamford, CT · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Presbyopia Quantitative refractive crosslinking

2Trials (company is sponsor)

Funding and NIH signals

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

  1. Trial start I: Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients. source ↗
  2. Trial start Not phased (device or behavioral study): Quantitative Refractive Crosslinking in Presbyopia Aged Patients source ↗

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT07208604Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients.INot yet recruitingSep 30, 20252026-08 (estimated)
NCT07137767Quantitative Refractive Crosslinking in Presbyopia Aged PatientsNot phased (device or behavioral study)Not yet recruitingAug 31, 20252026-08 (estimated)
Feedback